abilitycentral.orgCrawled Oct 24, 2026
The company evaluates accessibility resources with input from the disability community and experts.
Ability Central programs support schools, organizations, and individuals through assistive technology, workforce development, and community engagement.
Remembering a pioneering disability rights activist and leader who
The Articles Library provides articles, news stories, blog posts, white papers, videos, graphics, fact sheets, and reviews on research, technologies, and cultural insights related to Deaf, disabled, and neurodivergent communities.
Ability Central sponsors the 2026 Consumer Technology Association (CTA) Foundation competition, offering opportunities for tech companies to participate.
HapWare won the CES 2026 CTA Foundation Health Innovation Challenge with ALEYE, an assistive wearable for translating nonverbal communication cues into real-time feedback.
The CES 2026 CTA Foundation Health Innovation Challenge brought together global attendees to share ideas and connect with creators and business leaders in Las Vegas.
The page introduces the staff and board of directors overseeing programs for Deaf, disabled, and neurodivergent individuals.
The company advocates for communication as a fundamental human right and promotes equal opportunity to exercise it.
The page traces the history of the Stanford University School of Medicine, originally founded as the Medical Department of the University of the Pacific in San Francisco.
The Ability Central Portal Team assists with questions or comments about the Portal or Ability Central.
Ability Central is the philanthropic division of the California Communications Access Foundation (CCAF), a registered 501(c)(3) nonprofit organization founded in 2003.
Ability Central is a 501(c)3 nonprofit organization, and donations are tax-deductible.
Ability Central serves as an educator, convener, and resource for people with disabilities and their support networks.
Ability Central ensures its digital platforms are accessible to Deaf, disabled, and neurodivergent individuals.